GlassScriptPhysician profile
Elizabeth Constance
NPI 1003105214
$1,270.70
in general payments reported to CMS, 2019-2025
20 companies · $115 in 2025
The $115 reported for 2025 was less than what a typical Reproductive Endocrinology provider received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $259 · 2020: $60.16 · 2021: $206 · 2022: $227 · 2023: $153 · 2024: $250 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $519.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $518.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $265.19 | 2019-2024 | |
| Abbvie INC. | $180.19 | 2019-2023 | Liletta |
| Ferring Pharmaceuticals INC. | $151.50 | 2019-2024 | Menopur |
| Meditrina | $144.19 | 2021-2022 | |
| Coopersurgical, INC. | $79.76 | 2024-2025 | Stripper |
| Sumitomo Pharma America, INC. | $60.39 | 2023-2025 | Myfembree |
| Hologic Sales and Service, LLC | $55.23 | 2024-2025 | Fluent Fluid Management System, Myosure Tissue Removal Device, Omni Hysteroscope |
| Merck Sharp & Dohme LLC | $48.24 | 2019-2020 | |
| Baxter Healthcare | $41.93 | 2022 | |
| Myovant Sciences INC. | $40.65 | 2021-2022 | |
| Organon LLC | $38.28 | 2021 | |
| Tersera Therapeutics LLC | $33.95 | 2024 | Zoladex |
| Ibsa Pharma INC. | $23.86 | 2023 | Tirosint, Licart |
| Covidien LP | $23.31 | 2019 | |
| Virtus Pharmaceuticals LLC | $17.58 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galen US INC | $16.10 | 2019 | |
| Pfizer INC. | $14.31 | 2023 | |
| Agiliti Surgical, INC. | $13.19 | 2019 | |
| Boston Scientific Corporation | $11.56 | 2019 | |
| Novo Nordisk INC | $11.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Constance listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.